Nefazodone in the Treatment of Cocaine Dependence and Depression - 4

Completed · Phase 2 · Has a placebo group

Conditions studied: Cocaine-Related Disorders, Substance-Related Disorders

In brief

The purpose of this study is the use of Nefazodone in the treatment of cocaine dependence and depression comorbidity.

Key facts

Study ID

NCT00015210

Run by

Boston Medical Center

People needed

69

Starts

1997-02-01

Last updated by the study team

2015-07-30

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• DSM-IV diagnosis of cocaine dependence, Depression score of 12 or above and history of depression. Males and non-pregnant, non-nursing females 21-55 years of age.

You may not qualify if…

• Axis I diagnosis other than substance use disorder, major depression, anxiety of dysthymic disorder. Physiological dependence on alcohol. Significant medical or neurological history. Abnormal UA, CBC or Chem 23 (LFT's may be up to 3 times normal). Enrollment in an opiate-substitution treatment program within 45 days of enrollment in the present study.

Where it is running

• Boston University — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.